Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered imaging and clinical data curation platform, has announced that it has been selected by Calluna Pharma to support its study.
UST, a digital transformation solutions company, has partnered with ThinkBio.Ai, an AI-powered solutions provider for biopharmaceutical and healthcare organisations.
Cognizant has announced the official launch of the TriZetto AI Gateway, a foundational product designed to seamlessly integrate generative AI capabilities across Cognizant’s TriZetto ecosystem.
Sanome has secured Class IIb CE certification and MHRA approval for MEMORI, an AI-enabled warning system for the early prediction/prevention of healthcare‑associated infections (HAIs).
Norwalt, a specialist in custom-built automation and line integration machinery for complex manufacturing applications, announces its strategic partnership with ei3, a specialist in industrial Internet of Things (IIoT) solutions.
John Cogan, COO, Qinecsa outlines the opportunity presented by AI-driven automation to transform pharmacovigilance, both to address soaring workloads and costs, and to inject new strategic purpose into the function’s role.
David Staunton, industry transformation leader at Cognizant Life Science Manufacturing shares how life sciences companies are under immense pressure to deliver new treatments to a global population faster.
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, is launching two complementary initiatives to transform pharmacovigilance (PV) in response to growing member demand.
Professor Philipp Koellinger, co-founder and CEO of open science startup DeSci Labs, argues that peer review needs urgent reform and that AI can help pharma live up to its ideals.
Qureight, a techbio company accelerating drug development using its proprietary deep-learning image biomarkers and clinical data analytics platform, has announced the first results from a collaboration with Insilico Medicine.
